Web Access Research Portal

Researcher: Patchett, AL (Dr Amanda Patchett)

Fields of Research

Animal Immunology
Animal Cell and Molecular Biology
Cellular Immunology
Veterinary Immunology
Humoural Immunology and Immunochemistry
Proteomics and Intermolecular Interactions (excl. Medical Proteomics)
Infectious Agents
Host-Parasite Interactions
Gene Expression (incl. Microarray and other genome-wide approaches)

Research Objectives

Flora, Fauna and Biodiversity at Regional or Larger Scales
Immune System and Allergy
Control of Pests, Diseases and Exotic Species at Regional or Larger Scales
Expanding Knowledge in the Biological Sciences
Cancer and Related Disorders
Veterinary Biological Preventatives (e.g. Vaccines)
Infectious Diseases
Expanding Knowledge in the Medical and Health Sciences
Disease Distribution and Transmission (incl. Surveillance and Response)

Career Best Publications

Research Publications

Abstract B040: Imiquimod initiates tumor specific overload of the ER stress response in Tasmanian devil facial cancer cells; Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: translating science into survival
An oral bait vaccination approach for the Tasmanian devil facial tumor diseases; Expert Review of Vaccines
Analysis of toll-like receptor responses in the endangered Tasmanian devil; International Congress of Immunology
Application of metabolomics and proteomics for biomarker discovery and development of therapies for the transmissible cancer, Tasmanian Devil Facial Tumour Disease; The 22nd Annual Lorne Proteomics Symposium 2017
Curse of the Devil: Devil Facial Tumour Disease; Australasian Cytometry Society 38th Annual Scientific Meeting
Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii); Cellular and Molecular Life Sciences
Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease; PLoS ONE
Immunization strategies producing a humoral IgG immune response against devil facial tumor disease in the majority of Tasmanian devils destined for wild release; Frontiers in Immunology
OPINION: We canít risk nature taking its course against this most iconic Tasmanian animal
Targeting transmissible cancers in animals
The immunomodulatory small molecule imiquimod induces apoptosis in devil facial tumour cell lines; PL o S One
The toll-like receptor ligands Hiltonol® (polyICLC) and imiquimod effectively activate antigen-specific immune responses in Tasmanian devils (Sarcophilus harrisii); Developmental and Comparative Immunology
Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil; Developmental and Comparative Immunology
Transcriptome and proteome profiling reveals stress-induced expression signatures of imiquimod-treated Tasmanian devil facial tumor disease (DFTD) cells; OncoTarget
Two of†a†kind: transmissible Schwann cell cancers in†the†endangered Tasmanian devil (Sarcophilus harrisii); Cellular and Molecular Life Sciences

Research Projects

Can the DFTD tumour microenvironment influence vaccine responses in the Tasmanian devil?; University of Tasmania Foundation Inc (UTF)
Developing DFTD vaccination approaches to favour cell mediated anti-tumour immunity; University of Tasmania Foundation Inc (UTF)
Development of a devil facial tumour bait-vaccine for landscape-level distribution; University of Tasmania (UTAS)
Identification of host-tumour interactions driving immune evasion and survival of devil facial tumor disease; University of Tasmania (UTAS)

Research Candidate Supervision